Global Oligonucleotide Therapeutics Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3756195
- 81 Pages
- March 2020
- Healthcare
The global Oligonucleotide Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Oligonucleotide Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Antisense Oligonucleotide
Aptamer
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Neuromuscular Diseases
ATTR
Hepatic VOD
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Oligonucleotide Therapeutics Industry
Figure Oligonucleotide Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Oligonucleotide Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Oligonucleotide Therapeutics
1.2.2 Downstream
Table Application Segment of Oligonucleotide Therapeutics
Table Global Oligonucleotide Therapeutics Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Oligonucleotide Therapeutics Market by Type
3.1 By Type
3.1.1 Antisense Oligonucleotide
Table Major Company List of Antisense Oligonucleotide
3.1.2 Aptamer
Table Major Company List of Aptamer
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Type, in USD Million
Figure Global Oligonucleotide Therapeutics Market Growth 2015-2019, by Type, in USD Million
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Type, in Volume
Figure Global Oligonucleotide Therapeutics Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Oligonucleotide Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Oligonucleotide Therapeutics Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Biogen (Company Profile, Sales Data etc.)
4.1.1 Biogen Profile
Table Biogen Overview List
4.1.2 Biogen Products & Services
4.1.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Sarepta Therapeutics (Company Profile, Sales Data etc.)
4.2.1 Sarepta Therapeutics Profile
Table Sarepta Therapeutics Overview List
4.2.2 Sarepta Therapeutics Products & Services
4.2.3 Sarepta Therapeutics Business Operation Conditions
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Jazz Pharmaceuticals (Company Profile, Sales Data etc.)
4.3.1 Jazz Pharmaceuticals Profile
Table Jazz Pharmaceuticals Overview List
4.3.2 Jazz Pharmaceuticals Products & Services
4.3.3 Jazz Pharmaceuticals Business Operation Conditions
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Bausch & Lomb (Company Profile, Sales Data etc.)
4.4.1 Bausch & Lomb Profile
Table Bausch & Lomb Overview List
4.4.2 Bausch & Lomb Products & Services
4.4.3 Bausch & Lomb Business Operation Conditions
Table Business Operation of Bausch & Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Alnylam Pharmaceuticals (Company Profile, Sales Data etc.)
4.5.1 Alnylam Pharmaceuticals Profile
Table Alnylam Pharmaceuticals Overview List
4.5.2 Alnylam Pharmaceuticals Products & Services
4.5.3 Alnylam Pharmaceuticals Business Operation Conditions
Table Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dynavax Technologies (Company Profile, Sales Data etc.)
4.6.1 Dynavax Technologies Profile
Table Dynavax Technologies Overview List
4.6.2 Dynavax Technologies Products & Services
4.6.3 Dynavax Technologies Business Operation Conditions
Table Business Operation of Dynavax Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Kastle therapeutics (Company Profile, Sales Data etc.)
4.7.1 Kastle therapeutics Profile
Table Kastle therapeutics Overview List
4.7.2 Kastle therapeutics Products & Services
4.7.3 Kastle therapeutics Business Operation Conditions
Table Business Operation of Kastle therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Akcea Therapeutics (Company Profile, Sales Data etc.)
4.8.1 Akcea Therapeutics Profile
Table Akcea Therapeutics Overview List
4.8.2 Akcea Therapeutics Products & Services
4.8.3 Akcea Therapeutics Business Operation Conditions
Table Business Operation of Akcea Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Oligonucleotide Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Oligonucleotide Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Oligonucleotide Therapeutics Sales Revenue Share in 2019, by Company, in USD Million
Table Global Oligonucleotide Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Oligonucleotide Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Oligonucleotide Therapeutics Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Oligonucleotide Therapeutics Market Concentration, in 2019
Figure Europe Oligonucleotide Therapeutics Market Market Concentration, in 2019
Figure Asia-Pacific Oligonucleotide Therapeutics MMarket Concentration, in 2019
Figure South America Oligonucleotide Therapeutics Market Concentration, in 2019
Figure Middle East & Africa Oligonucleotide Therapeutics Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Neuromuscular Diseases
Figure Oligonucleotide Therapeutics Demand in Neuromuscular Diseases, 2015-2019, in USD Million
Figure Oligonucleotide Therapeutics Demand in Neuromuscular Diseases, 2015-2019, in Volume
6.1.2 Demand in ATTR
Figure Oligonucleotide Therapeutics Demand in ATTR, 2015-2019, in USD Million
Figure Oligonucleotide Therapeutics Demand in ATTR, 2015-2019, in Volume
6.1.3 Demand in Hepatic VOD
Figure Oligonucleotide Therapeutics Demand in Hepatic VOD, 2015-2019, in USD Million
Figure Oligonucleotide Therapeutics Demand in Hepatic VOD, 2015-2019, in Volume
6.1.4 Demand in Others
Figure Oligonucleotide Therapeutics Demand in Others, 2015-2019, in USD Million
Figure Oligonucleotide Therapeutics Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Oligonucleotide Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Figure Oligonucleotide Therapeutics Market Growth 2020-2025, by Application, in USD Million
Figure Oligonucleotide Therapeutics Market Share in 2025, by Application, in USD Million
Table Oligonucleotide Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Oligonucleotide Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Oligonucleotide Therapeutics Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Oligonucleotide Therapeutics Production 2015-2019, by Region, in USD Million
Table Oligonucleotide Therapeutics Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Oligonucleotide Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Region, in Volume
Table Global Oligonucleotide Therapeutics Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure North America Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Europe Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure South America Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Oligonucleotide Therapeutics Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Oligonucleotide Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Oligonucleotide Therapeutics Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Oligonucleotide Therapeutics
Table Application Segment of Oligonucleotide Therapeutics
Table Global Oligonucleotide Therapeutics Market 2015-2025, by Application, in USD Million
Table Major Company List of Aptamer
Table Major Company List of Others
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Type, in USD Million
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Type, in Volume
Table Global Oligonucleotide Therapeutics Market Forecast 2020-2025, by Type, in USD Million
Table Global Oligonucleotide Therapeutics Market Forecast 2020-2025, by Type, in Volume
Table Biogen Overview List
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Overview List
Table Business Operation of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jazz Pharmaceuticals Overview List
Table Business Operation of Jazz Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bausch & Lomb Overview List
Table Business Operation of Bausch & Lomb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alnylam Pharmaceuticals Overview List
Table Business Operation of Alnylam Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dynavax Technologies Overview List
Table Business Operation of Dynavax Technologies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kastle therapeutics Overview List
Table Business Operation of Kastle therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Akcea Therapeutics Overview List
Table Business Operation of Akcea Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Oligonucleotide Therapeutics Sales Revenue 2015-2019, by Company, in USD Million
Table Global Oligonucleotide Therapeutics Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Oligonucleotide Therapeutics Sales Volume 2015-2019, by Company, in Volume
Table Global Oligonucleotide Therapeutics Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Oligonucleotide Therapeutics Demand Forecast 2020-2025, by Application, in USD Million
Table Oligonucleotide Therapeutics Demand Forecast 2020-2025, by Application, in Volume
Table Oligonucleotide Therapeutics Market Growth 2020-2025, by Application, in Volume
Table Oligonucleotide Therapeutics Market Share in 2025, by Application, in Volume
Table Oligonucleotide Therapeutics Production 2015-2019, by Region, in USD Million
Table Oligonucleotide Therapeutics Production 2015-2019, by Region, in Volume
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Region, in USD Million
Table Global Oligonucleotide Therapeutics Market Share 2015-2019, by Region, in USD Million
Table Global Oligonucleotide Therapeutics Market 2015-2019, by Region, in Volume
Table Global Oligonucleotide Therapeutics Market Share 2015-2019, by Region, in Volume
Table North America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table North America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
Table Europe Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Europe Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
Table South America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table South America Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Oligonucleotide Therapeutics Market Size 2015-2019, by Country, in Volume
Table Oligonucleotide Therapeutics Market Forecast 2020-2025, by Region, in USD Million
Table Oligonucleotide Therapeutics Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
